Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01123759 · ClinicalTrials.gov registry record · NA

Healthful Seafood Consumption for Sensitive Populations

A NA study, sponsored by Purdue University.

Completed
Registry status
NA
Development phase
71
Enrollment target

NCT01123759: Completed NA study, sponsored by Purdue University.

NCT01123759 is a NA study that has completed, run by Purdue University. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01123759, a NA study, has completed, sponsored by Purdue University.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target

Study Summary

Fish can provide pregnant women with omega-3 fatty acids for fetal brain development but some fish contains high levels of mercury which is detrimental to fetal brain development. The hypothesis is that women who have previously consumed high mercury fish can reduce the mercury level in their bodies and improve their omega-3 levels in three months by eating fish that is high in omega-3 fatty acids and low in mercury.

Primary Outcome

The hair mercury after feeding low mercury fish for 3 months

Interventions

  • OTHER Feeding low mercury fish

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2008-01
Est. Completion 2009-12
Phase NA
Purdue University

141 total trials

What the finished NCT01123759 record still lists

NCT01123759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Feeding low mercury fish is the first listed.

NCT01123759 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01123759 about?

NCT01123759 is a clinical study titled "Healthful Seafood Consumption for Sensitive Populations". Fish can provide pregnant women with omega-3 fatty acids for fetal brain development but some fish contains high levels of mercury which is detrimental to fetal brain development. The hypothesis is that women who have previously consumed high mercury fish can reduce the mercury level in their bodies...

What is the current status of trial NCT01123759?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2008-01. Estimated completion is 2009-12.

What interventions are being tested in trial NCT01123759?

The interventions under investigation include: Feeding low mercury fish (OTHER).

Who is sponsoring clinical trial NCT01123759?

This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01123759's enrollment target sits among peer trials

71 1102nd of 2000 higher than 898 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01123759, the US trial registry maintained by the National Library of Medicine. NCT01123759 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.